Avenue Supermarts Limited Board Announces Key Management Restructuring

Avenue Supermarts Limited has announced significant changes to its senior management team, effective May 2, 2026. The board confirmed the upcoming conclusion of Mr. Chandrashekhar Bhave’s tenure as an Independent Director on May 16, 2026. Additionally, the company has implemented leadership shifts across its operations, risk management, and pharmacy business units, including the re-designation of Mr. Hitesh Shah as Chief Business Officer for Pharmacy and Food Services.

Leadership Transition and Board Changes

Avenue Supermarts Limited has officially recognized the conclusion of the second term of Mr. Chandrashekhar Bhave as an Independent Director. Mr. Bhave is set to vacate his office at the close of business on May 16, 2026. The company has expressed its gratitude for his contributions and guidance during his tenure.

Strategic Realignment of Senior Management

The company has approved a series of structural changes to its leadership team to optimize operational focus, effective May 2, 2026:

  • Mr. Hitesh Shah has been re-designated as Chief Business Officer – Pharmacy and Food Services. In his expanded role, he will assume oversight of the Food Business alongside his existing Pharmacy portfolio.
  • Mr. Ravi Sharma, currently Head of Risk and Compliance (Partner Ecosystem), will take on the additional responsibility of Internal Auditor for the 2026-27 financial year.
  • Mr. Rohit Mundhra is transitioning from his role as Internal Auditor to become the Regional Head – Operations (Rajasthan).
  • Mr. Stephen Thomas will continue to lead the Food Services division but will now report directly to Mr. Hitesh Shah.

Operational Impact

Following these organizational shifts, both Mr. Rohit Mundhra and Mr. Stephen Thomas will cease to be categorized as Senior Managerial Personnel due to changes in their respective reporting structures. The leadership team remains focused on maintaining governance and driving growth across the company’s core retail and pharmacy segments.

Source: BSE

Previous Article

Avenue Supermarts Limited Fiscal 2026 Investor Presentation Highlights Growth

Next Article

Advanced Enzyme Technologies Board to Consider Annual Financials and Dividend Payout